CAR T cells for childhood diffuse midline gliomas

CAR T cells for childhood diffuse midline gliomas, Published online: 07 May 2018; doi:10.1038/s41591-018-0031-9

Anti-GD2 chimeric antigen receptor (CAR)-modified T cells may be a new and innovative approach for the treatment of pediatric H3-K27M-mutant diffuse midline gliomas.

中文翻译：

---

CAR T细胞用于儿童弥漫性中线神经胶质瘤

CAR T细胞用于儿童弥漫性中线神经胶质瘤

用于儿童弥漫性中线神经胶质瘤的CAR T细胞，在线发布：2018年5月7日; doi：10.1038 / s41591-018-0031-9

抗GD2嵌合抗原受体（CAR）修饰的T细胞可能是治疗小儿H3-K27M突变型弥漫性中线神经胶质瘤的新方法。